TNXP Stock Summary and Trading Ideas (Tonix Pharmaceuticals Holding Corp. | NASDAQ:TNXP)

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Tonix Pharmaceuticals Holding Corp. trades on the NASDAQ stock market under the symbol TNXP.

As of April 19, 2024, TNXP stock price was flat at $0.16 with 1,057,481 million shares trading.

TNXP has a beta of 1.84, meaning it tends to be more sensitive to market movements. TNXP has a correlation of 0.03 to the broad based SPY ETF.

TNXP has a market cap of $15.29 million. This is considered a Sub-Micro Cap stock.

Last quarter Tonix Pharmaceuticals Holding Corp. reported $4 million in Revenue and -$.86 earnings per share. This fell short of revenue expectation by $-51,000 and exceeded earnings estimates by $.78.

In the last 3 years, TNXP stock traded as high as $284.00 and as low as $.12.

The top ETF exchange traded funds that TNXP belongs to (by Net Assets): VTI, VXF.

TNXP has underperformed the market in the last year with a price return of -95.0% while the SPY ETF gained +21.2%. TNXP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -43.5% and -7.7%, respectively, while the SPY returned +3.0% and -4.5%, respectively.

TNXP support price is $.14 and resistance is $.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNXP stock will trade within this expected range on the day.